Abbott Laboratories is showing strong growth potential with rising sales and EPS, though slightly overvalued. See why we are ...

Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for ...

On Wednesday, Abbott Laboratories (NYSE:ABT) reported third-quarter sales of $10.64 billion, up 4.9% year over year, beating ...

Abbott Laboratories narrowed its full-year profit outlook, raising the midpoint slightly, as strong demand for its diabetes ...

Investors happily greeted the latest news from Abbott Laboratories ( ABT 1.52%) on Hump Day. After the storied healthcare ...

(Reuters) - Abbott Laboratories slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates ...

周四，Piper Sandler调整了对Abbott Laboratories (NYSE:ABT)的展望，将目标价从之前的131美元上调至133美元，同时维持对该股票的增持评级。 这一变化是在Abbott公布第三季度业绩后做出的。该季度业绩超出了华尔街对收入和调整后每股收益(EPS)的预期，尽管其基本面收入增长略低于预期。 Abbott的医疗技术业务在第三季度表现出强劲增长，这有助于平衡营养和诊 ...

The Searle Company Limited (PSX: SEARL) has denied showing any interest in acquiring a 51 percent stake in Abbott ...

Abbott Laboratories (ABT) shares tick into positive territory in Wednesday's pre-market trading on its third quarter earnings ...

Abbott Laboratories is the #1 healthcare stock to own for consistent, market-beating returns over the long term. Q3 results ...

Abbott Laboratories (NYSE: ABT)公布了强劲的第三季度业绩,有机销售增长超过8%,调整后每股收益为1.21美元。该公司2023年第三次上调全年指引,称强劲的设备销售是主要驱动因素。 Abbott ...